Hi,
Thanks Dr Barai.
Here is the email from Ms. Nanita Waddell, Administrator Investor Relations
*********************
I apologize for being so long in answering your e-mail.ÿ As you can imagine, I've had numerous phone calls and e-mail messages to respond to -- I need two more ears and four more hands.ÿ
Somatogen is actually being acquired by Baxter and your Somatogen stock, unless you sell it prior to close of the deal, will be traded for Baxter stock.ÿ For each share of Somatogen that you hold, you will receive $9/share in Baxter common stock.ÿ For example, if Baxter's average price prior to close is $54/share, you will receive one share of BAX for every six share of SMTG ($9 x 6 = $54).ÿ Also, for each share of SMTG, you will receive one Contingent Deferred Payment Right (CPR) worth a future POTENTIAL payment of $2/share based on sales of Somatogen's recombinant technology.ÿ The CPRs are totally
separate from the stock, so you could actually sell your BAX stock and still own the CPRs.ÿ The CPRs will not be tradeable on any exchange, but are transferable if you choose to sell them or give them to someone.
Please let me know if you have additional questions.
Nanita Waddell
Administrator Investor Relations |
